← Every company
Ultragenyx Pharmaceutical Inc SEC Filings
What Ultragenyx Pharmaceutical Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
RARE overview →Filings on file
136
since Nov 7, 2016
Warning signs
0
none filed
Last results
Aug 4, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| May 18, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 19, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jun 21, 2024 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Sep 8, 2023 | Executive or director change 8-K | Read ↗ |
| Jul 12, 2023 | Executive or director change 8-K | Read ↗ |
| Jun 13, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 23, 2023 | Executive or director change 8-K | Read ↗ |
| Mar 14, 2023 | Executive or director change 8-K | Read ↗ |
| Nov 10, 2022 | Executive or director change 8-K | Read ↗ |
| Sep 15, 2022 | Executive or director change 8-K | Read ↗ |
| Apr 22, 2022 | Executive or director change 8-K | Read ↗ |
| Jun 30, 2021 | Executive or director change 8-K | Read ↗ |
| Apr 16, 2021 | Executive or director change 8-K | Read ↗ |
| Oct 13, 2020 | Executive or director change 8-K | Read ↗ |
| Sep 2, 2020 | Executive or director change 8-K | Read ↗ |
| Mar 6, 2020 | Executive or director change 8-K | Read ↗ |
| Nov 25, 2019 | Executive or director change 8-K | Read ↗ |
| Feb 4, 2019 | Executive or director change 8-K | Read ↗ |
| Sep 17, 2018 | Executive or director change 8-K | Read ↗ |
| Jun 8, 2018 | Executive or director change 8-K | Read ↗ |
| Apr 10, 2017 | Executive or director change 8-K | Read ↗ |
Source: Ultragenyx Pharmaceutical Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on RARE
Company overviewEverything on RARE in one place, with the price.Insider tradingWhat RARE's own officers and directors buy and sell.Planned salesSales RARE insiders have filed notice of.Who owns itEvery manager reporting a position in RARE.Funds holding itWhich funds and ETFs hold RARE, and how big a bet.LobbyingWhat RARE spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on RARE's account, and who they worked for.PatentsWhat RARE is filing at the patent office.